Zu den Inhalten springen

Cellular and Molecular Neuroimmunology Group

Cellular and Molecular Neuroimmunology Group, Head: PD Dr. Thomas Blank

Gut products account for approximately 10% of the human metabolome, which is unknown terrain in terms of impacting signaling pathways and interaction in human organs. Metabolites have an impact on neuroimmunological, cellular, and molecular processes that precede persistent diseases such as neurodegeneration. To uncover novel therapeutic targets and biomarkers, we are interested in defining causal multi-mechanism pathways throughout the gut-brain and other gut-organ axis that are linked to possible clinically significant outcomes. We employ a diverse collection of methods for metabolite identification and pathway characterization, including translational in-vivo animal models, in-vitro experiments, multi-omics analysis, electrophysiological, morphological screening, and human tissue.

Principal Investigator

PD Dr. Thomas Blank

University Clinic Freiburg

Institute of Neuropathology
Breisacher Straße 64
79106 Freiburg

Tel.: +49 761 270-63105
Fax: +49 761 270-50500